Lucas M A Goossens

Summary

Affiliation: Erasmus University
Country: The Netherlands

Publications

  1. pmc Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, P, O, Box 1738, 3000 Rotterdam, Dr, The Netherlands
    BMC Pulm Med 14:163. 2014
  2. pmc Evaluation of health care providers' role transition and satisfaction in hospital-at-home for chronic obstructive pulmonary disease exacerbations: a survey study
    Cecile M A Utens
    Department of Respiratory Medicine, Catharina Hospital, Eindhoven, The Netherlands
    BMC Health Serv Res 13:363. 2013
  3. doi request reprint Should I stay or should I go home? A latent class analysis of a discrete choice experiment on hospital-at-home
    Lucas M A Goossens
    Institute for Medical Technology Assessment Institute for Healthcare Policy and Management, Erasmus University, Rotterdam, The Netherlands Electronic address
    Value Health 17:588-96. 2014
  4. doi request reprint Cost-effectiveness of early assisted discharge for COPD exacerbations in The Netherlands
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Value Health 16:517-28. 2013
  5. pmc Adjusting for COPD severity in database research: developing and validating an algorithm
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Int J Chron Obstruct Pulmon Dis 6:669-78. 2011
  6. pmc Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial
    Cecile M A Utens
    Department of Respiratory Medicine, Catharina Hospital Eindhoven, Eindhoven, The Netherlands
    BMC Public Health 10:618. 2010
  7. doi request reprint An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University Medical Center, DR Rotterdam, The Netherlands
    Adv Ther 26:872-85. 2009
  8. doi request reprint Is the EQ-5D responsive to recovery from a moderate COPD exacerbation?
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Respir Med 105:1195-202. 2011
  9. doi request reprint Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues
    Maureen P M H Rutten-van Mölken
    Institute for Medical Technology Assessment Institute for Healthcare Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Pharmacoeconomics 30:271-302. 2012
  10. doi request reprint Not simply more of the same: distinguishing between patient heterogeneity and parameter uncertainty
    Pepijn Vemer
    Institute for Medical Technology Assessment iMTA, Erasmus University, Rotterdam, Netherlands PV, LMAG, MPMHRvM
    Med Decis Making 34:1048-58. 2014

Detail Information

Publications11

  1. pmc Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, P, O, Box 1738, 3000 Rotterdam, Dr, The Netherlands
    BMC Pulm Med 14:163. 2014
    ....
  2. pmc Evaluation of health care providers' role transition and satisfaction in hospital-at-home for chronic obstructive pulmonary disease exacerbations: a survey study
    Cecile M A Utens
    Department of Respiratory Medicine, Catharina Hospital, Eindhoven, The Netherlands
    BMC Health Serv Res 13:363. 2013
    ..To date, the impact on providers' roles is unknown and in addition, little is known about the satisfaction and acceptance of care providers involved in hospital-at-home...
  3. doi request reprint Should I stay or should I go home? A latent class analysis of a discrete choice experiment on hospital-at-home
    Lucas M A Goossens
    Institute for Medical Technology Assessment Institute for Healthcare Policy and Management, Erasmus University, Rotterdam, The Netherlands Electronic address
    Value Health 17:588-96. 2014
    ..This technique is rarely used in health economics...
  4. doi request reprint Cost-effectiveness of early assisted discharge for COPD exacerbations in The Netherlands
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Value Health 16:517-28. 2013
    ..An alternative is to treat suitable patients at home instead of in the hospital. This article reports on the cost-effectiveness and cost-utility of early assisted discharge in The Netherlands...
  5. pmc Adjusting for COPD severity in database research: developing and validating an algorithm
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Int J Chron Obstruct Pulmon Dis 6:669-78. 2011
    ..Previous database research has approximated COPD severity using demographics and healthcare utilization. This study aims to derive an algorithm for COPD severity using baseline data from a large respiratory trial (UPLIFT)...
  6. pmc Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial
    Cecile M A Utens
    Department of Respiratory Medicine, Catharina Hospital Eindhoven, Eindhoven, The Netherlands
    BMC Public Health 10:618. 2010
    ..Whether this type of service is cost-effective depends on the setting in which it is delivered and the way in which it is organised...
  7. doi request reprint An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University Medical Center, DR Rotterdam, The Netherlands
    Adv Ther 26:872-85. 2009
    ..This study assesses the cost-effectiveness of SMART compared with usual care in patients with mild-to-moderate persistent asthma treated by general practitioners in the Netherlands from a societal perspective...
  8. doi request reprint Is the EQ-5D responsive to recovery from a moderate COPD exacerbation?
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands
    Respir Med 105:1195-202. 2011
    ..To correctly estimate the cost-effectiveness of treatments that reduce COPD exacerbations, the utility gains from preventing exacerbations need to be measured. This requires utility measurement during exacerbations...
  9. doi request reprint Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues
    Maureen P M H Rutten-van Mölken
    Institute for Medical Technology Assessment Institute for Healthcare Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Pharmacoeconomics 30:271-302. 2012
    ..Guidelines for the pharmacological treatment of the disease recommend an individualized step-up approach in which treatment is intensified when results are unsatisfactory...
  10. doi request reprint Not simply more of the same: distinguishing between patient heterogeneity and parameter uncertainty
    Pepijn Vemer
    Institute for Medical Technology Assessment iMTA, Erasmus University, Rotterdam, Netherlands PV, LMAG, MPMHRvM
    Med Decis Making 34:1048-58. 2014
    ..The single-loop PSA should not be used in CE research. It disregards the fundamental differences between heterogeneity and sampling uncertainty and overestimates uncertainty as a result...
  11. doi request reprint The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands
    Lucas M A Goossens
    Institute for Medical Technology Assessment, Erasmus University Medical Center, Rotterdam, The Netherlands
    Vaccine 26:1118-27. 2008
    ..Based on the current study, it is clear that mass vaccination with Rotarix against rotavirus gastroenteritis can be attractive, from an economic and a health care perspective...